Vancouver biotech startup AbSci raises $65 million

Vancouver biotech startup AbSci raises $65 million

No comments

AbSci, a Vancouver company with an innovative technology for biomanufacturing, said Tuesday it has raised an additional $65 million to increase production and support its research. The company has a technique it calls “protein printing.” AbSci claims it will enable production of biologic drugs made from living organisms, drugs […]

Click here to view original web page at www.oregonlive.com

Any thought?

This site uses Akismet to reduce spam. Learn how your comment data is processed.